Literature DB >> 19752588

Reasons for cannabis use and effects of cannabis use as reported by patients with psychotic disorders.

N Dekker1, D H Linszen, L De Haan.   

Abstract

BACKGROUND: Cannabis is one of the most commonly used substances in patients with a psychotic disorder and is associated with a higher risk of psychotic relapses. Identifying reasons for cannabis use and subjective effects in patients with psychotic disorders can provide insight into the functions of cannabis use, and this may lead to targeted interventions.
METHODS: A literature search of the PubMed and PsycINFO databases for articles published from 1985 till 2008 was carried out to review studies that examined self-reported reasons for cannabis use and self-reported effects of cannabis use in patients with psychotic disorders.
RESULTS: Only a few studies were found that specifically assessed reasons for and effects of cannabis use. Despite the heterogeneity in the study samples and methodology, patients commonly reported that their reasons for cannabis use were enhancement of positive affect, relief of dysphoria and social enhancement. Fewer patients reported reasons related to relief of psychotic symptoms or relief of side effects of medication. Frequently reported positive effects of cannabis were positive changes in affect and relaxation. A large proportion of patients reported that cannabis negatively affected positive symptoms.
CONCLUSIONS: Patients suffering from psychotic disorder report using cannabis mainly for affect regulation and socialization, despite the awareness that cannabis has a negative effect on positive symptoms. In spite of the heterogeneity of the studies, the results turned out to be broadly comparable and support the external validity of this review to a broad range of cannabis-using patients with psychotic disorder. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 19752588     DOI: 10.1159/000236906

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  12 in total

1.  The prevalence of substance use disorders and psychiatric disorders as a function of psychotic symptoms.

Authors:  William V Lechner; Jennifer Dahne; Kevin W Chen; Alison Pickover; Jessica M Richards; Stacey B Daughters; C W Lejuez
Journal:  Drug Alcohol Depend       Date:  2013-01-03       Impact factor: 4.492

Review 2.  Cannabis Use Among Patients With Psychotic Disorders.

Authors:  Matthew E Hirschtritt; Kelly C Young-Wolff; Daniel H Mathalon; Derek D Satre
Journal:  Perm J       Date:  2021-05-12

3.  Do patients think cannabis causes schizophrenia? - A qualitative study on the causal beliefs of cannabis using patients with schizophrenia.

Authors:  Anna Buadze; Rudolf Stohler; Beate Schulze; Michael Schaub; Michael Liebrenz
Journal:  Harm Reduct J       Date:  2010-09-28

Review 4.  Cannabis and development of dual diagnoses: A literature review.

Authors:  Rebecca C Hanna; Jessica M Perez; Subroto Ghose
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-09       Impact factor: 3.829

Review 5.  [Clinical prognosis of schizophrenic patients with cannabis addiction. Between nihilism and hope].

Authors:  T Schnell
Journal:  Nervenarzt       Date:  2014-09       Impact factor: 1.214

6.  Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders.

Authors:  Maju Mathew Koola; Robert P McMahon; Heidi J Wehring; Fang Liu; Kristen M Mackowick; Kimberly R Warren; Stephanie Feldman; Joo-Cheol Shim; Raymond C Love; Deanna L Kelly
Journal:  J Psychiatr Res       Date:  2012-05-16       Impact factor: 4.791

7.  Developing a theoretical framework for persistent cannabis use among young adults with first episode psychosis.

Authors:  Leslie Marino; Samantha E Jankowski; Rick Kent; Michael L Birnbaum; Ilana Nossel; Jean-Marie Alves-Bradford; Lisa Dixon
Journal:  Early Interv Psychiatry       Date:  2021-05-16       Impact factor: 2.732

8.  The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia.

Authors:  Verity C Leeson; Isobel Harrison; Maria A Ron; Thomas R E Barnes; Eileen M Joyce
Journal:  Schizophr Bull       Date:  2011-03-09       Impact factor: 9.306

9.  Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.

Authors:  Felipe V Gomes; Francisco S Guimarães; Anthony A Grace
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-13       Impact factor: 5.176

Review 10.  Cannabis and psychosis: Neurobiology.

Authors:  Amresh Shrivastava; Megan Johnston; Kristen Terpstra; Yves Bureau
Journal:  Indian J Psychiatry       Date:  2014-01       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.